InvestorsHub Logo

lightrock

07/09/19 8:51 PM

#23186 RE: greens12 #23185

Simple actually, at least for a very short term

One big dog strategy is to play the pre-reporting pop on (all) biotech and then bail, skipping all the risk of maybe maybe not.

pijoe

07/09/19 9:36 PM

#23187 RE: greens12 #23185

In my mind it will have a nice pop, for me to guess is what it is, a guess. We have been way undervalued for some time now. Once we have good data, will we be fairly valued or receive a large pop and still be undervalued comparatively. Like I said I believe we should be over $20, really closer to 25/30 in my mind just because of end of phase 3 status with comparables to other companies, the possibilities or hope and math alone. Valueing a company over that is based on perceived value and hope as it still hasnt produced a single dollar(except rental fees from subleasing). The real exciting price per share comes from a sale of Multikine(hopefully royalties from future indications as well) or actual receiving of monies from sales, which wont happen for some time(that will make the company actually solvent that is).